Vaginal progesterone gel is non-inferior to intramuscular progesterone in efficacy with acceptable tolerability for luteal phase support: A prospective, randomized, multicenter study in China

التفاصيل البيبلوغرافية
العنوان: Vaginal progesterone gel is non-inferior to intramuscular progesterone in efficacy with acceptable tolerability for luteal phase support: A prospective, randomized, multicenter study in China
المؤلفون: Xuefeng Huang, Shuyu Wang, Liyi Cai, Qun Lv, Rong Li, Qiongfang Wu, Hong Ye, Jie Qiao, Fang Wang, Xiujuan Chen, Hongbin Chi, Yimin Zhu, Gui-min Hao, Cuilian Zhang, Xingling Wang, Yunxia Cao, Yunshan Zhang, Xuehong Zhang, Hong Li, Yingpu Sun
المصدر: European Journal of Obstetrics & Gynecology and Reproductive Biology. 237:100-105
بيانات النشر: Elsevier BV, 2019.
سنة النشر: 2019
مصطلحات موضوعية: Adult, China, medicine.medical_specialty, Pregnancy Rate, medicine.medical_treatment, Fertilization in Vitro, Luteal Phase, Luteal phase, Chorionic Gonadotropin, Injections, Intramuscular, Pregnancy, medicine, Humans, Vaginal bleeding, Adverse effect, Progesterone, Luteal support, Gynecology, In vitro fertilisation, business.industry, Pregnancy Outcome, Obstetrics and Gynecology, Administration, Intravaginal, Pregnancy rate, Reproductive Medicine, Tolerability, Vaginal Creams, Foams, and Jellies, Female, medicine.symptom, business, Intramuscular injection
الوصف: Objectives Research suggests the efficacy of progesterone for luteal phase support in assisted reproduction cycles using gonadotropin-releasing hormone analogues. Our study objective was to compare the efficacy of two available preparations of progesterone, vaginal gel and intramuscular injection, for luteal phase support in assisted reproduction cycles. Study design This study included data gathered from 18 reproductive centers in China. Subjects were randomly allocated to receive progesterone gel or intramuscular progesterone (IMP). The progesterone gel group received micronized progesterone in gel (8%, 90 mg) once daily; the IMP group received IMP (progesterone oil) once daily. The ongoing pregnancy rate was calculated (number of women with a viable pregnancy at 12 weeks divided by the number of women who had undergone an oocyte pickup cycle). Results A total of 1313 patients were enrolled in the study, 1248 of whom began treatment. The intention-to-treat set included 527 and 531 patients in the gel and IMP groups, respectively. The ongoing pregnancy rate in the progesterone gel group was non-inferior to that in the IMP group (48.4% [95% confidence interval (CI): 44.0, 52.8] vs. 46.3% [95% CI: 42.0, 50.7]); the between-group rate difference was 2.1% (−4.0, 8.1). There was no difference between the gel group and IMP group on most secondary endpoints, including implantation rate, biochemical pregnancy rate, clinical pregnancy rate, multiple pregnancy rate, early abortion rate, and vaginal bleeding rate, but there was a between-group difference in luteal phase bleeding rate. The safety analysis showed no difference in the incidence of total adverse events. Conclusions Progesterone gel showed good efficacy and safety outcomes and therefore provides an alternative method of luteal support in Chinese in vitro fertilization patients.
تدمد: 0301-2115
DOI: 10.1016/j.ejogrb.2019.04.012
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e1d0b2c9c3e70669b292efc454cb2e6
https://doi.org/10.1016/j.ejogrb.2019.04.012
Rights: CLOSED
رقم الانضمام: edsair.doi.dedup.....1e1d0b2c9c3e70669b292efc454cb2e6
قاعدة البيانات: OpenAIRE
الوصف
تدمد:03012115
DOI:10.1016/j.ejogrb.2019.04.012